Article info

Download PDFPDF

Extended report
Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study

Authors

  1. Correspondence to Dr Marco Gattorno, UO Pediatria 2, Istituto G. Gaslini, Via G. Gaslini 5, Genova 16147, Italy; marcogattorno{at}ospedale-gaslini.ge.it
View Full Text

Citation

Gattorno M, Obici L, Cattalini M, et al
Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study

Publication history

  • Received December 15, 2015
  • Revised April 27, 2016
  • Accepted May 17, 2016
  • First published June 7, 2016.
Online issue publication 
December 09, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.